Streetbeat News

Products Services

AIXI

Xiao-I Corporation (NASDAQ:AIXI) has announced a partnership with a leading telecommunications provider to deploy its AI Chatbot solution in Q2. This collaboration aims to enhance customer service efficiency, reduce operational costs, and provide 24/7 personalized support.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:22 pm

ARDX

Ardelyx presented new data on the educational needs for managing IBS-C at the 2024 AANP Annual Conference, highlighting the importance of cross-discipline healthcare education.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:19 pm

NVDA

SMH

SOXX

TSM

Taiwan Semiconductor Manufacturing Co (TSMC) received government approval to invest an additional $10.26 billion in its second fabs in Kumamoto, Japan, and Arizona, USA. This investment aims to enhance advanced process technologies and meet the growing demand for AI and other applications. TSMC stock is trading higher on this news.

Portfolio Pulse from Anusuya Lahiri

June 28, 2024 | 12:13 pm

NRXP

NRx Pharmaceuticals plans to file two New Drug Applications (NDAs) in 2024 for NRX-101 and NRX-100, targeting bipolar depression, akathisia, and suicidal depression. These drugs have received Breakthrough Therapy and Fast Track Designations, respectively. Potential revenue from these drugs could exceed $150 per NRXP share. Additionally, HOPE Therapeutics is progressing towards a public listing.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:11 pm

GE

The U.S. Army has accepted GE Aerospace's T901 engines to enhance the turbine engine program for UH-60 Black Hawk flight testing. Financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:04 pm

BTDR

Bitdeer Technologies Group (NASDAQ:BTDR) has entered into a strategic partnership with the Monroe County Port Authority in Ohio to secure an additional 570 MW of power capacity, increasing its total capacity to 2.5 GW globally. This move strengthens Bitdeer's infrastructure for Bitcoin mining, high-performance computing, and AI.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:03 pm

RYTM

Rhythm Pharmaceuticals announced that the European Medicines Agency's CHMP has adopted a positive opinion recommending marketing authorization for IMCIVREE to include children aged 2 to under 6 with obesity due to specific genetic conditions. A decision from the European Commission is expected in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:02 pm

SLNO

Soleno Therapeutics has submitted a New Drug Application to the FDA for DCCR extended-release tablets aimed at treating Prader-Willi syndrome in individuals aged four and older with hyperphagia.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:02 pm

BTCUSD

New research from CryptoQuant indicates a significant decrease in Bitcoin miners' selling pressure, suggesting a potential upward trend for Bitcoin prices. This shift could lead to a more optimistic outlook for the cryptocurrency market moving into Q3 2024.

Portfolio Pulse from Murtuza Merchant

June 28, 2024 | 12:01 pm

CMND

Clearmind Medicine has been granted patent approval in Hong Kong for its treatment of binge behaviors, expanding its intellectual property protection in the psychedelic space.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:00 pm